newsfilter
← Latest News
GlobeNewswire·

Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (NASDAQ:MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney